Related Experiment Video
Updated: Nov 18, 2025
Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics
Yu Chen1, Xiaoqing Liu1, Yanxia Guo1
1Institute of Pathogen Biology and Immunology of College of Biology, Hunan Provincial Key Laboratory of Medical Virology, Hunan University, Changsha, China; College of Biology, Hunan University, Changsha, China.
Abstract:
Drug delivery systems based on genetically engineered oncolytic bacteria have properties that cannot be achieved by traditional therapeutic interventions. Thus, they have attracted considerable attention in cancer therapies. Attenuated bacteria can specifically target and actively penetrate tumor tissues and play an important role in cancer suppression as the "factories" of diverse anticancer drugs. Over the past decades, several bacterial strains including Salmonella and Clostridium have been shown to effectively retard tumor growth and metastasis, and thus improve survival in preclinical models or clinical cases. In this review, we summarize the unique properties of oncolytic bacteria and their anticancer mechanisms and highlight the particular advantages compared with traditional strategies. With the current research progress, we demonstrate the potential value of oncolytic bacteria-based drug delivery systems for clinical applications. In addition, we discuss novel strategies of cancer therapies integrating oncolytic bacteria, which will provide hope to further improve and standardize the current regimens in the near future.
Insights
Genetically engineered oncolytic bacteria offer unique cancer therapy advantages. These engineered bacteria act as drug delivery systems, targeting tumors and improving survival, showing great potential for clinical applications.
Area of Science:
- Oncology
- Microbiology
- Biotechnology
Background:
- Traditional cancer therapies have limitations.
- Genetically engineered oncolytic bacteria present novel therapeutic properties.
- These bacteria can be engineered as targeted drug delivery systems.
Purpose of the Study:
- To review the unique properties and anticancer mechanisms of oncolytic bacteria.
- To highlight the advantages of oncolytic bacteria over traditional cancer treatment strategies.
- To discuss the potential of oncolytic bacteria-based drug delivery systems for clinical applications.
Main Methods:
- Review of preclinical and clinical studies on bacterial cancer therapy.
- Analysis of anticancer mechanisms employed by oncolytic bacteria.
- Evaluation of bacterial strains like Salmonella and Clostridium in tumor suppression.
Main Results:
- Oncolytic bacteria effectively target and penetrate tumor tissues.
- Bacterial strains such as Salmonella and Clostridium have demonstrated efficacy in retarding tumor growth and metastasis.
- These systems function as in-situ "factories" for diverse anticancer drugs.
Conclusions:
- Oncolytic bacteria-based drug delivery systems hold significant potential for clinical cancer therapy.
- Integrating oncolytic bacteria into cancer treatment regimens offers hope for improved and standardized therapeutic outcomes.
- Further research and novel strategies are crucial for advancing this field.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Microorganisms in Medicine and Therapeutics
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...